American Capital Advisory LLC Has $162,000 Stake in UnitedHealth Group Incorporated $UNH

American Capital Advisory LLC raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 147.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 518 shares of the healthcare conglomerate’s stock after acquiring an additional 309 shares during the quarter. American Capital Advisory LLC’s holdings in UnitedHealth Group were worth $162,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of UNH. Bayforest Capital Ltd boosted its position in shares of UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd raised its holdings in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after acquiring an additional 50 shares during the last quarter. Glass Jacobson Investment Advisors llc increased its stake in UnitedHealth Group by 80.9% in the 2nd quarter. Glass Jacobson Investment Advisors llc now owns 123 shares of the healthcare conglomerate’s stock valued at $38,000 after buying an additional 55 shares during the last quarter. Kentucky Trust Co increased its stake in UnitedHealth Group by 53.8% in the 2nd quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock valued at $45,000 after buying an additional 50 shares during the last quarter. Finally, Cloud Capital Management LLC purchased a new stake in UnitedHealth Group in the 1st quarter valued at about $53,000. Institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on the stock. Morgan Stanley increased their target price on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research report on Friday, September 12th. Baird R W lowered shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Bank of America boosted their price target on shares of UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Wednesday, October 8th. UBS Group lifted their price objective on shares of UnitedHealth Group from $378.00 to $430.00 and gave the stock a “buy” rating in a report on Wednesday, October 29th. Finally, Wells Fargo & Company lifted their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Eighteen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and an average price target of $397.12.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $333.87 on Tuesday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. The company’s 50-day moving average is $344.08 and its 200 day moving average is $324.95. The stock has a market capitalization of $302.43 billion, a P/E ratio of 17.43, a P/E/G ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. During the same quarter in the previous year, the company earned $7.15 earnings per share. UnitedHealth Group’s quarterly revenue was up 12.2% on a year-over-year basis. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is 46.14%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.